Project Oncology®

Dr. Rami Manochakian, a thoracic medical oncologist at the Mayo Clinic, dives into three clinical trials on developments in lung cancer treatment that were presented at the 2021 American Society of Clinical Oncology Annual Meeting.

ReachMD host Dr. Jacob Sands joins us to share key updates that were presented on lung cancer at the American Society of Clinical
Oncology Annual Meeting.

Dr. Fred R. Hirsch, Executive Director at the Center for Thoracic Oncology in the Tisch Cancer Institute at Mount Sinai and Associate Director of Biomarker Discovery for TCI discusses key studies presented at the 2021 American Society of Clinical Oncology meeting surrounding updates in lung cancer research.

How do surgical delays play a role in breast cancer outcomes? Dr. Samilia Obeng-Gyasi, an Assistant Professor of Surgery at Ohio State University, shares insight from her presentation at the 2021 American Society of Clinical Oncology Annual Meeting.

In the field of breast cancer, how far have targeted therapies come? Dr. Maryam Lustberg, Assistant Professor of Internal Medicine in the Division of Medical Oncology at Ohio State University, shares some insight into the latest developments in the treatment of early-stage HER2-positive breast cancer.

Current cancer screening methods like mammograms, colonoscopies, and CT scans are all effective in detecting cancers, but they don’t always detect cancers as early as we’d like them to, resulting in missed and delayed diagnoses. Could new technology like multicancer early detection (MCED) be the answer to addressing current unmet needs in cancer screening? Find out with Dr. Charles Turck and Dr. Lincoln Nadauld, an oncologist and the Vice President and Chief of Precision Health and Academics at Intermountain Healthcare.

For the 3% to 4% of patients with non-small cell lung cancer (NSCLC) who harbor a MET exon 14 skipping mutation, the prognosis is grave. MET gene dysregulation may also play a role in the emergence of resistance to EGFR TKI therapy in patients with EGFR-mutated NSCLC, further complicating treatment. Join our case discussion as Dr. Paul Paik and Dr. Josh Sabari highlight the importance of identifying MET gene aberrations in patients with NSCLC.

What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell lung cancer treatment developments with Dr. Millie Das, a Clinical Associate Professor of Medical Oncology at Stanford University and Chief of Oncology at the Veteran’s Affairs Palo Alto Healthcare System.

Dr. Osita Onugha, thoracic surgeon at the Providence Specialty Medical Group in Santa Monica, California, is here to share multidisciplinary strategies for the treatment of non-small cell lung cancer.

Dr. Charles Turck sits down with Dr. Christine Bestvina, Assistant Professor of Medicine in the Section of Hematology and Oncology at University of Chicago Medicine, to discuss strategies to implement molecular diagnostics into clinical practice.